Last reviewed · How we verify
NCT03794505
Quality of Life and Pain With Infiltration or Suprascapular Nerve Block in Glenohumeral Arthirtis
Phase 3 trial testing Methylprednisolone Acetate in Shoulder Arthritis in 40 participants. Completed in 30 August 2018.
30 August 2018
Quick facts
| Lead sponsor | Instituto Mexicano del Seguro Social |
|---|---|
| Phase | Phase 3 |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | double |
| Primary purpose | treatment |
| Enrollment | 40 |
| Start date | 1 April 2018 |
| Primary completion | 30 August 2018 |
| Estimated completion | 30 August 2018 |
| Sites | 1 location across Mexico |
Drugs / interventions tested
- Methylprednisolone Acetate (METHYLPREDNISOLONE ACETATE) — full drug profile →
- Lidocaine 2% Injectable Solution — full drug profile →
- Ropivacaine HCl Inj 7.5 MG/ML — full drug profile →
Conditions studied
- Shoulder Arthritis — all drugs for Shoulder Arthritis →
Sponsor
Instituto Mexicano del Seguro Social — full company profile →
Who can join
Adults 18 to 80, any sex, with Shoulder Arthritis. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Efficacy in pain and health related quality of life of suprascapular nerve block ultrasound guided and glenohumeral infiltration in glenohumeral arthritis
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT03794505
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Methylprednisolone Acetate
Trials testing the same drug.
- NCT03913702 — Subacromial Methylprednisolone Versus Ketorolac for Shoulder Impingement · Phase 2 · terminated
Other recruiting trials for Shoulder Arthritis
Currently open trials in the same condition.
- NCT06319911 — AETOS Shoulder System · recruiting
- NCT04209504 — Evaluating Hemidiaphragmatic Paralysis With Prolonged Neural Blockade From an Interscalene Brachial Plexus Block · recruiting
- NCT04984291 — Zimmer Biomet Shoulder Arthroplasty PMCF · NA · recruiting
Other Instituto Mexicano del Seguro Social trials
Trials by the same sponsor.
- NCT07536009 — "Effectiveness of a Telerehabilitation Program Versus a Conventional Rehabilitation Program in Patients With Subacromial · NA · not yet recruiting
- NCT06632184 — Peritoneal Lavage Using Saline or Saline With Ondansetron for Pain Control After Laparoscopic Cholecystectomy · Phase 4 · active not recruiting
- NCT07073846 — Effect of Lidocaine-Dexmedetomidine on Pain, Inflammation, and Oxidative Stress After Bariatric Surgery. · Phase 4 · recruiting
- NCT07406971 — Safety of Transmucosal Capsaicin Sphenopalatine Ganglion Stimulation in Acute Ischemic Stroke · Phase 2 · recruiting
- NCT07134504 — Primary Prostatic Lymphoma on a 66 Year-old Male in Mexico. · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03794505 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Instituto Mexicano del Seguro Social
- Last refreshed: 8 January 2019
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03794505.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing